Statin Intolerance
Čimbenici kojiutječu na liječenje statinima
Croatian translation of the “Factors Affecting Patients’ Use of Statins” infographic.
Resources
Resources developed by IAS and its member societies
Imaging
Leading Insights: A Conversation with Professors Jessica M. Peña and Alexander van Rosendael
Watch the newest episode of IAS’ Leading Insights series to learn from Prof. Jessica M. Peña and Prof. Alexander van Rosendael as they discuss the latest study findings using CONFIRM2, the largest registry of quantification of atherosclerosis. IAS received an unrestricted grant from Cleerly to develop this resource. About Leading InsightsLeading Insights is a video series in which IAS’ global experts discuss recent research findings about breakthrough diagnostic tools, therapies and devices relevant to the diagnosis and management of […]
Imaging
Understanding the Prognostic Value of AI-Based Quantitative Coronary CT
Artificial Intelligence Quantitative Computed Tomography (AI-QCT) uses AI technology to analyze the amount, composition, and stenosis of coronary artery plaque. IAS received an unrestricted grant from Cleerly to develop this resource.
Inflammation
Inflammation Academy Lecture Series
Recordings of the live lectures from the Inflammation Academy, held in Madrid on August 28, 2025
Triglycerides
Formation of Triglycerides
This first graphic explains the formation of triglycerides and how their concentration in blood serves as a biomarker for TGRL, which promote the formation of atheroma.
Triglycerides
Risks Associated with Triglyceride Concentration
This second graphic shows the associated risk for different concentrations of triglycerides in the blood.
Triglycerides
Behaviors to Reduce the Risk of Hypertriglyceridemia
This third graphic demonstrates some lifestyle behaviors that can reduce the risk of hypertriglyceridemia.
Triglycerides
Therapeutic Options for Severe Hypertriglyceridemia
This fourth graphic outlines the available therapeutic options for severe hypertriglyceridemia as well as novel therapies in development.
Triglycerides
Icosapent Ethyl for CV Risk Reduction
This fifth graphic delineates how icosapent ethyl can be used for CV risk reduction as demonstrated by the REDUCE-IT trial.
Imaging
Atherosclerosis Webinar Series
Cleerly, the International Atherosclerosis Society, and Women As One, in collaboration with the Baim Institute for Clinical Research, have produced a webinar series designed to change how healthcare providers understand, detect, and manage coronary artery disease by going beyond symptoms and stenosis to the true biology of atherosclerosis. Episode 1: Atherosclerosis: Basic Concepts and Current Understanding Presented by […]
Triglycerides
Hypertriglyceridemia and ASCVD Risk
A video series about hypertriglyceridemia, its health implications and therapeutic options for optimal management of patients.
Lipoprotein(a)
The Brussels International Declaration on Lipoprotein(a) Testing and Management
The Brussels International Declaration on Lp(a) Testing and Management was co-created by the Lp(a) International Task Force and global leaders at the Lp(a) Global Summit, held in Brussels, Belgium, on March 24–25, 2025. The event, organized by FH Europe Foundation, brought together scientific experts, people with the lived experience of elevated Lp(a) and policy makers from the European Institutions and World Health Organization. The World Heart Federation, Global Heart Hub, and European Alliance for Cardiovascular Health and scientific organizations such as European Atherosclerosis Society, and International Atherosclerosis Society were formal partners.
Promoting the scientific understanding of atherosclerosis
Newsletters
-
The IAS e-Newsletter is a digest of the latest from the IAS and its Constituent Member Societies.
-
Going beyond statins, this resource provides the latest information about primary prevention for clinicians.
